Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer TherapiesNing Zhao, Yangjie Huang, Yung-Hua Wang, et al.
ACS Central Science|May 2, 2019
Measuring Dynamic Changes in the Labile Iron Pool in Vivo with a Reactivity-Based Probe for Positron Emission TomographyRyan K Muir, Ning Zhao, Junnian Wei, et al.
Life Science Alliance|December 29, 2019
Oscillatory cAMP signaling rapidly alters H3K4 methylationTyler C Huff, Vladimir Camarena, David W Sant, et al.
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
The Journal of Experimental Medicine|March 9, 2022
Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumorsHonglin Jiang, Ryan K Muir, Ryan L Gonciarz, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial TargetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
ACS Infectious Diseases|September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparumJohn M Bennett, Kurt E Ward, Ryan K Muir, et al.
ACS Infectious Diseases|February 11, 2021
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19Kas Steuten, Heeyoung Kim, John C Widen, et al.
British Journal of Cancer|January 8, 2009
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancerZ Kote-Jarai, S Jugurnauth, S Mulholland, et al.
Pageof 25